Ítem
Solo Metadatos
Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model
dc.creator | Yandar, Nubia | spa |
dc.creator | Pastorin, Giorgia | spa |
dc.creator | Prato, Maurizio | spa |
dc.creator | Bianco, Alberto | spa |
dc.creator | Patarroyo, Manuel Elkin | spa |
dc.creator | Lozano, José Manuel | spa |
dc.date.accessioned | 2020-05-26T00:02:05Z | |
dc.date.available | 2020-05-26T00:02:05Z | |
dc.date.created | 2008 | spa |
dc.description.abstract | We have covalently conjugated an N-terminus Plasmodium vivax apical membrane antigen-1 (AMA-1) peptide to functionalized carbon nanotubes (f-CNT). Immunological characterization of this molecular conjugate revealed that the immunogen-AMA-1 peptide was appropriately presented after being conjugated to CNTs as well as being recognized by BALB/c polyclonal antibodies. Subsequent experiments lead us to assess the AMA-1 peptide alone, as well as the CNT-peptide conjugate regarding rodent malarial infection. Remarkably, the peptide effectively controlled and delayed Plasmodium berghei-challenged animals' parasitaemia. The peptide-CNT conjugate displayed similar immunological properties to the peptide alone by protecting or delaying malarial infection. The peptide presentation by f-CNT to the immune system thus constitutes a promising approach for synthetic malarial vaccine formulation since the immunogen peptide conformation is well preserved. © 2008 Elsevier Ltd. All rights reserved. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1016/j.vaccine.2008.08.014 | |
dc.identifier.issn | 0264410X | |
dc.identifier.issn | 13588745 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23447 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 5873 | |
dc.relation.citationIssue | No. 46 | |
dc.relation.citationStartPage | 5864 | |
dc.relation.citationTitle | Vaccine | |
dc.relation.citationVolume | Vol. 26 | |
dc.relation.ispartof | Vaccine, ISSN:0264410X, 13588745, Vol.26, No.46 (2008); pp. 5864-5873 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-53449093079&doi=10.1016%2fj.vaccine.2008.08.014&partnerID=40&md5=f24cf4ad2c3fdb0f0fb8cc9ebd87a1a3 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Apical membrane antigen 1 | spa |
dc.subject.keyword | protozoan | eng |
dc.subject.keyword | Drug carrier | spa |
dc.subject.keyword | Polyclonal antibody | spa |
dc.subject.keyword | Amino terminal sequence | spa |
dc.subject.keyword | Animal experiment | spa |
dc.subject.keyword | Animal model | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Bagg albino mouse | spa |
dc.subject.keyword | Conjugation | spa |
dc.subject.keyword | Controlled study | spa |
dc.subject.keyword | Drug delivery system | spa |
dc.subject.keyword | Drug structure | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Immune system | spa |
dc.subject.keyword | Immunogenicity | spa |
dc.subject.keyword | Malaria | spa |
dc.subject.keyword | Mouse | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Parasitemia | spa |
dc.subject.keyword | Plasmodium berghei | spa |
dc.subject.keyword | Plasmodium vivax | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Alleles | spa |
dc.subject.keyword | Amino acid sequence | spa |
dc.subject.keyword | Animals | spa |
dc.subject.keyword | Antigens | eng |
dc.subject.keyword | Blotting | eng |
dc.subject.keyword | Cytokines | spa |
dc.subject.keyword | Drug delivery systems | spa |
dc.subject.keyword | Enzyme-linked immunosorbent assay | spa |
dc.subject.keyword | Female | spa |
dc.subject.keyword | Fluorescent antibody technique | spa |
dc.subject.keyword | Genes | eng |
dc.subject.keyword | Hla-dr antigens | spa |
dc.subject.keyword | Malaria | spa |
dc.subject.keyword | Malaria vaccines | spa |
dc.subject.keyword | Membrane proteins | spa |
dc.subject.keyword | Mice | spa |
dc.subject.keyword | Mice | eng |
dc.subject.keyword | Microscopy | eng |
dc.subject.keyword | Molecular sequence data | spa |
dc.subject.keyword | Nanotubes | spa |
dc.subject.keyword | Plasmodium berghei | spa |
dc.subject.keyword | Plasmodium vivax | spa |
dc.subject.keyword | Protozoan proteins | spa |
dc.subject.keyword | Vaccines | eng |
dc.subject.keyword | Apical membrane antigen 1 (ama-1) | spa |
dc.subject.keyword | Functionalized carbon nanotubes (f-cnt) | spa |
dc.subject.keyword | Synthetic vaccine delivery system | spa |
dc.title | Immunological profile of a Plasmodium vivax AMA-1 N-terminus peptide-carbon nanotube conjugate in an infected Plasmodium berghei mouse model | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |